✦ LIBER ✦

319 Treatment with pegylated-interferon alfa 2B in relapsers to standard interferon + ribavirin in chronic hepatitis C: Efficacy and safety results from a randomized multicentric French study

✍ Scribed by Isabelle Portal; Danielle Botta-Fridlund; Marc Bouliere; Michel Rotily; Philippe Halfon; Patrice Couzigou; Karl Barange; V. Canva; Dominique Larrey

Book ID: 119530228
Publisher: John Wiley and Sons
Year: 2003
Tongue: English
Weight: 119 KB
Volume: 38
Category: Article
ISSN: 0270-9139
DOI: 10.1016/s0270-9139(03)80362-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Retreatment with pegylated interferon al

Retreatment with pegylated interferon alfa-2B plus ribavirin with or without amantadine of patients with chronic hepatitis C relapsing after standard interferon and ribavirin: Results of a randomized controlled trial

✍ A. Ciancio; C. Giordanino; A. Smedile; M. Tabone; S. Martini; S. Framarin; G. Ca 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 231 KB

Pegylated interferon alfa-2b plus ribavi

Pegylated interferon alfa-2b plus ribavirin in patients with chronic hepatitis C: A trial in prior nonresponders to interferon monotherapy or combination therapy and in combination therapy relapsers: Final results

✍ Jacobson, Ira M.; Ahmed, Furqaan; Russo, Mark W.; Brown, Robert S.; Lebovics, Ed 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 240 KB

A randomized 4-arm multicenter study of

A randomized 4-arm multicenter study of interferon alfa-2b plus ribavirin in the treatment of patients with chronic hepatitis C relapsing after interferon monotherapy

✍ Giorgio Saracco; Alda Olivero; Alessia Ciancio; Silvia Carenzi; Antonina Smedile 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB

A randomized 4-arm multicenter study of

A randomized 4-arm multicenter study of interferon alfa-2b plus ribavirin in the treatment of patients with chronic hepatitis C relapsing after interferon monotherapy

✍ Saracco, G 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB

Interferon alfa-2b in combination with r

Interferon alfa-2b in combination with ribavirin for the treatment of chronic hepatitis C in children: Efficacy, safety, and pharmacokinetics

✍ Regino P. González-Peralta; Deirdre A. Kelly; Barbara Haber; Jean Molleston; Kar 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 215 KB 👁 3 views

Chronic hepatitis C virus (HCV) infection is usually asymptomatic in children, but significant liver disease may occur. We evaluated the efficacy, safety, and pharmacokinetics of interferon alfa-2b and ribavirin in children with chronic HCV. We determined the optimal ribavirin dose in an initial coh

1042 EFFICACY AND SAFETY RESULTS OF ALBI

1042 EFFICACY AND SAFETY RESULTS OF ALBINTERFERON ALFA-2B IN COMBINATION WITH RIBAVIRIN IN INTERFERON-ALFA TREATMENT NAIVE PATIENTS WITH GENOTYPE 2 OR 3 CHRONIC HEPATITIS C

✍ Nelson, D.; Benhamou, Y.; Chuang, W.L.; Lawitz, E.; Flisiak, R.; Rodriguez-Torre 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB